GLP-1 Telehealth: What Prescribers Need to Know in Florida

You’ve spent years mastering psychiatric care. Now patients are asking about weight-loss medications—and you’re wondering if this is a distraction or an opportunity.

Here’s the reality: GLP-1 prescribing isn’t just trending—it’s exploding. By 2025, an estimated 20 million Americans (6% of the population) were actively taking GLP-1 drugs like Ozempic or Wegovy. That’s a 600% increase in weight-loss usage over six years. Demand is outpacing supply of obesity medicine specialists, and patients are turning to any qualified prescriber they can find—including psychiatrists.

If you’re thinking about adding GLP-1 weight management to your practice, you’re not alone. Nearly half of psychiatrists surveyed in late 2023 were already prescribing or recommending these medications. The question isn’t whether there’s a market—it’s whether you can tap into it profitably without burning out.

Let’s break down exactly how to get GLP-1 patients, what the economics really look like, and how to scale this service line sustainably.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

The Patient Overlap Is Already There

Many of your current patients are ideal GLP-1 candidates. Psychiatric medications—especially antipsychotics and mood stabilizers—commonly cause weight gain. Patients complain about it during med checks. They ask if there’s anything you can do.

Now there is something you can do. And by addressing medication-induced weight gain, you’re not just improving their physical health—you’re potentially improving treatment adherence and overall mental well-being. When patients feel better about their bodies, they’re more likely to stay on their psychiatric medications.

Beyond medication side effects, psychiatric patients frequently struggle with:

• Binge eating disorder or emotional overeating
• Depression-related weight gain and inactivity
• Anxiety that manifests in stress eating
• Body image issues that compound mood disorders

About 75% of Americans are overweight or obese. Given that psychiatric conditions correlate with higher obesity rates, your patient panel likely skews even higher. The potential GLP-1 candidates are already in your practice—you just need to identify them and offer the service.

Your Behavioral Expertise Is a Differentiator

GLP-1 medications aren’t magic pills. They work best when combined with behavioral change—exactly where psychiatrists excel. You understand motivation, habit formation, emotional regulation, and relapse prevention. These skills directly apply to weight management.

Generic weight-loss clinics might prescribe semaglutide, but they often lack the expertise to address:

• Why a patient self-sabotages when they start losing weight
• How to manage anxiety around food restriction
• What to do when weight plateaus trigger depressive episodes
• Whether mood changes are medication side effects or underlying psychiatric issues

By positioning yourself as the provider who treats the whole person—addressing both the metabolic and psychological aspects of obesity—you attract patients seeking comprehensive care. This isn’t a pivot away from psychiatry; it’s an expansion that leverages your core competencies.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

How to Actually Acquire GLP-1 Patients

Start With Your Existing Panel

The lowest-cost patient acquisition is converting current patients. During routine psychiatric follow-ups, screen for weight-related concerns:

• ‘How are you feeling about your weight since starting this medication?’
• ‘Have you thought about medical weight management?’
• ‘I’ve started offering GLP-1 medications for patients interested in weight loss. Want to discuss whether it might be right for you?’

Document BMI at appointments (most patients meet criteria: BMI ≥30, or ≥27 with comorbidities). For those who qualify and express interest, schedule a dedicated weight management consult. You’re not cold-calling—you’re offering an additional service to people who already trust you.

Expected yield: If you have 100 psychiatric patients and 30-40% are obese or overweight with comorbidities, that’s 30-40 potential GLP-1 candidates. Convert even 25% in the first six months and you’ve added 8-10 weight-management patients with zero external marketing spend.

Leverage Telehealth Platforms

Here’s where economics get real. Many providers think they can acquire patients cheaply through DIY marketing—Google Ads, SEO, Psychology Today listings. The reality is harsher.

DIY Patient Acquisition Costs (Reality Check):

• Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ when you factor in wasted ad spend, testing, and optimization time.
• SEO: Takes 6-12 months of consistent content creation, technical optimization, and link building before generating meaningful patient flow. You need either in-house expertise (your time) or an agency ($1,500-3,000/month). Effective, but slow and expensive upfront.
• Directory Listings: Psychology Today charges monthly fees ($29.95-39.95/month per listing) and you compete with hundreds of providers on the same page. Zocdoc charges per booking ($35-100+ per patient) plus monthly subscription fees. Quality varies.

Total monthly DIY marketing spend for meaningful results: $3,000-5,000+ with uncertain ROI for the first 6-12 months.

Telehealth Platform Model (The Smarter Play):

Platforms like Klarity Health operate on a pay-per-appointment model—similar to Zocdoc but built for providers who want predictable, pre-qualified patient flow without gambling on marketing.

How it works:

• No upfront marketing spend or monthly subscription fees
• Klarity handles patient acquisition (advertising, SEO, intake) and matches qualified patients to your specialty and availability
• You pay a standard listing fee per new patient lead who books with you
• Built-in telehealth infrastructure—no separate platform costs
• Both insurance and cash-pay patient flow
• You control your schedule and only pay when you see patients

The ROI math: Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books. That’s guaranteed ROI—every dollar spent directly correlates to a patient visit. For providers starting out or scaling quickly, this removes financial risk entirely.

Other platforms to consider: WeightWatchers (recently acquired a telehealth provider to handle GLP-1 demand), Ro, Calibrate, and specialized obesity telehealth startups. Each has different economics, but the principle is the same: they handle patient acquisition, you handle clinical care.

Build Local Referral Networks

Don’t overlook old-school networking. Primary care physicians, endocrinologists, therapists, and dietitians all encounter patients who need weight management but lack capacity to manage it themselves.

Outreach strategy:

• Send brief intro emails or letters to local providers: ‘I’m a psychiatrist offering comprehensive weight management including GLP-1 medications. I’m accepting referrals for patients seeking medical weight loss with behavioral support.’
• Emphasize you’ll send updates and refer patients back for routine care
• Offer to co-manage patients (you handle weight meds, they handle primary care)

Why this works: Many PCPs are overwhelmed and appreciate offloading time-intensive weight management. Therapists and dietitians recognize when their clients need medical intervention but can’t prescribe. By making referrals easy (clear contact info, fast response times), you become their go-to resource.

Independent Marketing (If You Have Time and Budget)

If you want to build your own patient pipeline:

SEO (Long-term, high ROI):

• Create content answering common questions: ‘Can a psychiatrist prescribe Ozempic?’ ‘GLP-1 for SSRI weight gain?’ ‘Telehealth weight loss in [Your State]’
• Optimize your website for local search terms
• Expect 6-12 months before meaningful traffic

Social Media (Fastest organic reach):

• Share educational content about obesity, mental health, and GLP-1s
• Patient success stories (with consent)
• Position as the expert who treats mind AND body

Paid Ads (Fast but expensive):

• Target geo-specific audiences interested in weight loss
• Emphasize your psychiatric credentials as a differentiator
• Budget $2,000-3,000/month minimum for testing and scale

Reality check: Most solo providers don’t have the expertise or patience for effective DIY marketing. If you go this route, plan to either invest serious time learning or hire professionals—both are expensive. Platforms that handle acquisition for you are often the better economic choice early on.

Cash-Pay vs Insurance: Which Model Works?

The Cash-Pay Case

Most GLP-1 telehealth practices operate cash-pay, and for good reason:

Insurance barriers are real. As of 2024, only 13 state Medicaid programs (including California and Pennsylvania) covered GLP-1s for weight loss. Many private insurers exclude obesity medications entirely or require extensive prior authorizations. Patients often end up paying out-of-pocket for medications anyway—so why not for visits too?

Cash-pay advantages:

• Simple operations—no claims, denials, or pre-auths
• Higher revenue per visit ($150-300 for initial consult, $75-150 for follow-ups)
• Can offer subscription models (monthly fee includes consults, coaching, meds)
• Attracts motivated patients who value convenience

Reality: Patients willing to pay $200-1,300/month for medications are often willing to pay $100-200/month for professional guidance. Frame it as an investment in their health, not a cosmetic expense.

The Insurance Case

Accepting insurance widens your potential patient base, especially for lower-income populations who can’t afford cash-pay.

Insurance advantages:

• Access to patients who can only afford treatment if covered
• Potential for higher volume (though lower per-visit revenue)
• Some employers are starting to cover obesity medications—early mover advantage

Insurance challenges:

• Lower reimbursement (often $80-150 for E/M codes)
• Prior authorizations for medications (time-consuming)
• Documentation requirements
• Some insurers might deny obesity treatment as ‘not medically necessary’

Middle ground: Many providers charge cash for initial comprehensive evaluations (which insurance underpays) but accept insurance for follow-ups or related services (diabetes management, nutritional counseling). Be transparent with patients about what’s covered and what’s not.

Scaling Without Burning Out

Set Realistic Volume Goals

Start small. Don’t try to see 20 new GLP-1 patients next week. Begin with 2-3 per week while you refine workflows, then scale gradually. Your goal isn’t just volume—it’s sustainable volume that doesn’t kill your quality of life.

Streamline Your Workflow

Standardize intake:

• Digital forms gather history before the first visit (weight history, comorbidities, psych meds, diet/exercise)
• Pre-appointment lab orders (A1c, TSH, liver panel) so results are ready
• Clinical checklists ensure you cover essentials (contraindications, informed consent, goal-setting) without forgetting steps

Efficient follow-ups:

• GLP-1 patients need monthly visits during dose titration (first 3-6 months), then can space to every 2-3 months once stable
• Use templates for routine monitoring (weight, side effects, medication adjustments)
• Brief visits (15-20 minutes) focused on medical management

Leverage technology:

• Telehealth platform with integrated video, e-prescribing, and messaging
• Automated appointment reminders
• Patient portals for questions (reduces phone tag)

Delegate Non-Specialist Tasks

You don’t need to do everything. Health coaches, RNs, or dietitians can handle:

• Initial diet and exercise counseling
• Weekly check-ins and weight tracking
• Managing routine patient questions
• Group support sessions

This frees you to focus on what only you can do: prescribing decisions, managing complex cases, addressing psychiatric comorbidities.

Protect Your Time

Set boundaries:

• Dedicate specific days/hours to GLP-1 consults (e.g., Tuesday and Thursday afternoons)
• Limit daily patient volume to sustainable numbers
• Use ‘office hours’ for portal messages rather than responding 24/7

Monitor burnout signs: If you’re feeling exhausted, resentful, or quality is slipping, reassess. It might mean temporarily capping new patients, hiring help, or adjusting your model.

The Bottom Line: Why This Opportunity Makes Sense Now

The GLP-1 market isn’t slowing down—it’s accelerating. Patients are actively seeking providers, many obesity medicine specialists are maxed out, and psychiatrists are already trusted by patients struggling with weight and mental health comorbidities.

You have three choices:

1. Ignore it and watch patients go elsewhere (losing both weight-management revenue and potentially your psychiatric patients who feel you’re not addressing their needs)
2. DIY marketing and spend months and thousands of dollars with uncertain results
3. Join a platform that handles patient acquisition, leverage your existing panel, and build referral networks—start seeing GLP-1 patients within weeks with predictable economics

The providers who move early in high-growth markets capture disproportionate value. GLP-1 prescribing isn’t a fad—it’s a fundamental shift in how we treat obesity. As a psychiatrist, you’re uniquely positioned to deliver comprehensive care that addresses both the biological and behavioral aspects of weight loss.

Your next step: Identify 5-10 current patients who might benefit from GLP-1 therapy. Have the conversation. See how they respond. If interest is there, you’ve just acquired your first weight-management patients with zero marketing spend.

From there, decide whether to scale via platforms, marketing, referrals, or a combination. But start. Because while you’re deliberating, thousands of patients are starting GLP-1 medications every week—and they’re looking for a provider who understands not just weight loss, but the psychological journey that comes with it.

That’s you. Time to grow.

FAQ

Can psychiatrists legally prescribe GLP-1 medications like Ozempic?

Yes. Psychiatrists (MD/DO) have full prescriptive authority for GLP-1 medications in all states. These are not controlled substances, so there are no federal restrictions on telehealth prescribing. You must be licensed in the patient’s state, but once licensed, you can prescribe semaglutide, tirzepatide, and other GLP-1s for obesity or off-label use as you would any other medication.

Do I need special training or certification to prescribe GLP-1s?

No mandatory certification exists, but you should be comfortable with basic obesity medicine principles: BMI criteria, contraindications (history of medullary thyroid cancer, pancreatitis), dose titration protocols, and managing common side effects (nausea, constipation). Many psychiatrists pursue CME in obesity medicine or join organizations like the Obesity Medicine Association for guidance. Formal certification (like ABOM) isn’t required but can boost confidence and marketing credibility.

How much can I realistically earn adding GLP-1 services?

Depends on your model. Cash-pay: Initial consults often bill $200-300, follow-ups $100-150. If you see 10 new GLP-1 patients/month (with ongoing follow-ups), that’s $2,000-3,000/month in new revenue from initials alone, plus recurring follow-up income. Insurance: Lower per-visit ($80-150), but higher volume potential if you accept insurance. Some providers report adding $5,000-10,000+/month in revenue once scaled. The key is balancing volume with sustainability—more patients = more income, but also more time unless you delegate effectively.

What if a patient has psychiatric side effects from GLP-1 medications?

This is where your psychiatric expertise shines. Early reports suggested possible mood changes or suicidal ideation, but FDA reviews in 2026 found no clear causal link and removed suicide warnings from labels. Still, monitor patients for mood shifts, anxiety, or depression—especially if they have psychiatric history. Your ability to assess and manage these concerns is a major value-add over generic weight-loss clinics. Document discussions about mental health at each visit and adjust treatment if needed (dose reduction, discontinuation, or adding/modifying psychiatric meds).

How do I handle patients who just want GLP-1 for cosmetic weight loss?

Set clear expectations upfront. GLP-1 medications are FDA-approved for obesity (BMI ≥30 or ≥27 with comorbidities) or diabetes, not cosmetic use in healthy-weight individuals. Screen patients carefully—if someone with BMI 23 wants to lose 10 pounds for a wedding, that’s not appropriate. Explain that these are medical treatments for chronic disease, not vanity drugs. Patients who meet medical criteria but focus heavily on appearance can still be treated, but emphasize health outcomes (reduced diabetes risk, improved mobility) over aesthetics. If a patient insists on inappropriate use, decline and refer to a bariatric specialist if needed.

Do I need malpractice insurance that covers weight-loss prescribing?

Check your current policy. Most physician malpractice insurance covers prescribing within your scope of practice, and obesity treatment falls under general medicine for an MD/DO. However, some insurers might consider it a specialty service. Contact your carrier to confirm coverage and disclose you’re prescribing GLP-1 medications. If you’re an NP/PA, ensure your policy doesn’t exclude services outside your certified specialty. Adding this disclosure protects you if a claim arises.

What states allow psychiatric NPs to prescribe GLP-1s independently?

Full independence: California (after 3 years as 103 NP, starting 2026), New York (after 3,600 hours), Illinois (after 4,000 hours + education for FPA). Require physician collaboration: Texas, Pennsylvania, Florida (for psych NPs—FL’s autonomy applies only to primary care NPs). Check your state’s current NP practice laws, as these evolve. Even in collaborative states, NPs can prescribe GLP-1s—you just need a supervising physician agreement in place.

Sources

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage) — May 27, 2025 — www.axios.com

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’ — October 20, 2025 — www.confectionerynews.com

3. PharmaNewsIntelligence via Schizophrenia Forum – ‘Psychiatrists recommend Ozempic’ — November 6, 2023 — forum.schizophrenia.com

4. Medical Director Co. – ‘Texas Weight Loss Clinic & Telehealth Compliance Guide’ — 2025 — www.medicaldirectorco.com

5. SingleAim Health – ‘Nurse Practitioner Collaborative Agreement Templates: 50-State Guide’ — 2023 — www.singleaimhealth.com

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is